Effects of angiotensin II and losartan in the forearm of patients with essential hypertension

被引:0
|
作者
Baan, J
Chang, PC
Vermeij, P
Pfaffendorf, M
van Zwieten, PA
机构
[1] Leiden Univ, Med Ctr, Dept Nephrol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Clin Pharm, NL-2300 RC Leiden, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Pharmacotherapy, NL-1105 AZ Amsterdam, Netherlands
关键词
angiotensin II; losartan; hypertension; forearm blood flow;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective Angiotensin II type 1 receptor-mediated constrictor effects may be modulated by hypertension-related vascular changes, changes in receptor function and in neurohumoral activity. Design The forearm blood flow (FBF) effects of angiotensin II, methoxamine, and losartan were investigated in essential hypertensive patients. Minimal forearm vascular resistance was measured to determine structural vascular changes. Methods Seven hypertensive patients were selected, and seven matched normotensives. Angiotensin II (0.01-10 ng/kg per min) was infused during predilatation by sodium nitroprusside (6.1 +/- 0.6 ng/kg per min) before and during losartan infusion (0.3-3 mu g/kg per min). Methoxamine (0.2-2 mu g/kg per min) was co-infused with the nitric oxide synthase inhibitor N-G-monomethyl-L-arginine. FBF, measured by venous occlusion plethysmography, was expressed as the change in FBF ratio (FBFinfused arm/FBFnon-infused arm). Results Baseline FBF (infused arm) was increased by sodium nitroprusside from 2.56 +/- 0.80 to 5.46 +/- 0.92 (P< 0.05) and from 2.66 +/- 0.25 to 5.42 +/- 0.40 ml/100 ml per min (P< 0.05) in the hypertensive and normotensive group, respectively. Baseline forearm vascular resistance (FVR) was higher in the hypertensive than in the normotensive group [51 +/- 8 versus 33 +/- 3 mmHg/(ml/100 ml per min); P< 0.05]. Angiotensin II caused a maximal change in FBF ratio (E-max) by -70 +/- 3 and -72 +/- 6% in the hypertensive and normotensive group, respectively (NS). Tachyphylaxis did not occur. Infusions of losartan at 0.3, 1 and 3 mu g/kg per min reduced the E-max values from -70 +/- 3 to -50 +/- 5, -45 +/- 5 and -15 +/- 2%, respectively, in the hypertensive group, and from -72 +/- 6 to -62 +/- 4, -45 +/- 2 and -32 +/- 2%, respectively, in the normotensive group (NS). Infusion of methoxamine significantly reduced the FBF ratio by -58 +/- 6 and -69 +/- 5% in the hypertensive and normotensive groups, respectively (NS). Minimal FVR, after forearm ischemia, was the same in hypertensives and normotensives, namely 3.2 +/- 0.7 and 3.2 +/- 0.4 mmHg/(ml per 100 ml per min), respectively (NS). Conclusions Angiotensin II type 1- and alpha(1)-mediated vascular effects were unchanged by essential hypertension. Baseline FVR was greater in the hypertensives than in the normotensives, while minimal FVR was the same. These results indicate that the forearm vascular bed of the patient group studied does not show important structural and renin-angiotensin system-related functional changes as a result of hypertension. J Hypertens 16:1299-1305 (C) 1998 Lippincott Williams & Wilkins.
引用
收藏
页码:1299 / 1305
页数:7
相关论文
共 50 条
  • [31] Effects of valsartan with or without benazepril on blood pressure, angiotensin II, and endoxin in patients with essential hypertension
    Ke, YS
    Tao, YY
    Yang, H
    Yu, GH
    ACTA PHARMACOLOGICA SINICA, 2003, 24 (04) : 337 - 341
  • [32] EFFECTS OF ANGIOTENSIN II ANTAGONISM ON ELASTIC AND STRUCTURAL PROPERTIES OF LARGE ARTERIES IN PATIENTS WITH ESSENTIAL HYPERTENSION
    Korzh, O.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 46 - 47
  • [33] The Effects of Salt and Glucose Intake on Angiotensin II and Aldosterone in Obese and Nonobese Patients with Essential Hypertension
    Alaagib, Nouralsalhin
    Sukkar, Mohammed
    Kardash, Mohammed
    INTERNATIONAL JOURNAL OF HYPERTENSION, 2020, 2020
  • [34] Pharmacoeconomic Aspects of Angiotensin II Receptor Blockers in Patients with Essential Hypertension
    Viet Thanh Truong
    Boersma, Cornelis
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 78 - 78
  • [35] Angiotensin receptor antagonist Losartan improves endothelial function of epicardial coronary arteries in patients with essential hypertension
    Deng, YB
    Yang, HY
    Li, CL
    Chang, Q
    CLINICAL CARDIOLOGY, 2002, 25 (09) : 422 - 428
  • [36] Effects of losartan, an angiotensin II receptor antagonist, on the fibrinolytic system in hypertensive patients
    Saito, M
    Kawasaki, S
    Hashiba, T
    Chen, CJ
    Hatakeyama, H
    Asakura, H
    Kikuchi, M
    Matsuda, T
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1999, 70 (01) : 60 - 61
  • [37] Cell membrane "stiffness" and effects of losartan in essential hypertension
    Zhumanova, AK
    Dzhusipov, AK
    EUROPEAN HEART JOURNAL, 2000, 21 : 107 - 107
  • [38] TIME-COURSE OF LOSARTAN BLOCKADE OF ANGIOTENSIN-II HYPERTENSION VERSUS BLOCKADE OF ANGIOTENSIN-II FAST PRESSOR EFFECTS
    GORBEAOPPLIGER, VJ
    MELARAGNO, MG
    POTTER, GS
    PETIT, RL
    FINK, GD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 271 (02): : 804 - 810
  • [39] Losartan, angiotensin II type I receptor blocker, augments vascular function in patients with hypertension
    Higashi, Yukihito
    Nishioka, Keniji
    Umemura, Takashi
    Jitsuiki, Daisuke
    Goto, Chikara
    Nakamura, Shuji
    Hidaka, Takayuki
    Takemoto, Hiroaki
    Chayama, Kazuaki
    Yoshizumi, Masao
    JOURNAL OF HYPERTENSION, 2006, 24 : 230 - 230
  • [40] Losartan influences behavioural effects of angiotensin II in rats
    Kulakowska, A
    Karwowska, W
    Wisniewski, K
    Braszko, JJ
    PHARMACOLOGICAL RESEARCH, 1996, 34 (3-4) : 109 - 115